Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans

Acta Physiologica Scandinavica

Volumn 161, Issue 2, 1997, Pages 211-220

  Ottosson Seeberger, A ^a   Lundberg, J M ^b   Alvestrand, A ^a   Ahlborg, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Blood flow; Blood pressure; Endothelin; Euglycaemic clamp; Glucose uptake; Insulin resistance; Skeletal muscle

Indexed keywords

ENDOTHELIN 1; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; LEG BLOOD FLOW; MALE; MUSCLE BLOOD FLOW; NORMAL HUMAN; PRIORITY JOURNAL; TECHNIQUE;

EID: 0030849449     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1997.00212.x     Document Type: Article

References (49)

1. Ahlborg, G., Weitzberg, E. & Lundberg, J.M. 1994. Endothelin-1 infusion reduces splanchnic glucose production in humans. J Appl Physiol 77, 121-126.
2. Ahlborg, G., Weitzberg, E. & Lundberg, J.M. 1995a. Metabolic and vascular effects of circulating endothelin-1 during moderately heavy prolonged exercise. J Appl Physiol 78, 2294-2300.
3. Ahlborg, G., Weitzberg, E. & Lundberg, J.M. 1995b. Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans. J Appl Physiol 79, 141-145.
4. Baron, A.D. 1994. Hemodynamic actions of insulin. Am J Physiol 267 (Endocrinol Metab 30), E187-E202.
5. Baron, A.D. 1996. The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes 45, S105-S109.
6. Baron, A.D., Brechtcl, G., Johnson, A., Fineberg, N., Henry, D.P. & Steinberg, H.O. 1994. Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. J Clin Invest 93, 2453-2462.
7. Boulanger, C. & Lüscher, T.F. 1990. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85, 587-590.
8. Brun, A. 1951. A rapid method for the determination of paraaminohippuric acid in kidney function tests. J Lab Clin Med 37, 955-958.
9. Byyny, R.L., LoVerde, M., Lloyd, S., Mitchell, W. & Draznin, B. 1992. Cytosolic calcium and insulin resistance in elderly patients with essential hypertension. Am J Hypertens 5, 459-464.
10. Chin, J.E., Dickens, M., Tavare, J.M. & Roth, R.A. 1993. Overexpression of protein kinase C isoenzymes α, βI, γ, and ε in cells overexpressing the insulin receptor. J Biol Chem 268, 6338-6347.
11. Chou, Y.C., Perng, J.C., Juan, C.C., Jang, S.Y., Kwok, C.F., Chen, W.L., Fong, J.C. & Ho, L.T. 1994. Endothelin-1 inhibits insulin-stimulated glucose uptake in isolated rat adipocytes. Biochem Biophys Res Commun 202, 688-693.
12. Corbally, M.T. 1988. Development and application of a novel technique for the study of amino acid transport and regional blood flow in-vivo. Thesis. National University of Ireland, Dublin.
13. DeFronzo, R.A., Bonadonna, R.C. & Ferrannini, E. 1992. Pathogenesis of NIDDM. A balanced overview. Diabetes care 15, 318-368.
14. DeFronzo, R.A., Gunnarsson, R., Björkman, O., Olsson, M. & Wahren, J. 1985. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type II) diabetes mellitus. J Clin Invest 149-155.
15. Ferri, C., Bellini, C., Desideri, G., Di Francesco, L., Baldoncini, R., Santucci, A. & De Mania, G. 1995a. Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 44, 431-436.
16. Ferri, C., Carlomagno, A., Coassin, S., Baldoncini, R., Cassone Faldetta, M.R., Laurenti, O., Properzi, G., Santucci, A. & De Mattia, G. 1995b. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes care 18, 226-233.
17. Hemsén, A., Ahlborg, G., Ottosson-Seeberger, A. & Lundberg, J.M. 1995. Metabolism of big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Regul Pept 55, 287-297.
18. Henry, R.J. 1974. In: R.J. Henry (ed.) Clinical Chemistry, p. 723, 2nd edn. Hagerstown, Harper & Row.
19. Higashi, Y., Oshima, T., Sasaki, N., Ishioka, N., Nakano, Y., Ozono, R., Yoshimura, M., Ishibashi, K., Matsuura, H. & Kajiyama, G. 1997. Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension. Hypertension 29, 280-285.
20. Ikeda, U., Yamamoto, K., Maeda, Y., Shimpo, M., Kanbe, T. & Shimada, K. 1997. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 29, 65-69.
21. Inishi, Y., Okuda, T., Arakawa, T. & Kurokawa, K. 1994. Insulin attenuates intracellular calcium responses and cell contraction caused by vasoactive agents. Kidney Int 45, 1318-1325.
22. Jorfeldt, L. & Wahren, J. 1971. Leg blood flow during exercise in man. Clin Sci 41, 459-473.
23. Kahn, A.M., Seidel, C.L., Allen, J.C., O'Neil, R.G., Shelat, H. & Song, T. 1993. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 22, 735-742.
24. Kohno, M., Yasunari, K., Murakawa, K.I., Yokokawa, K., Horio, T., Fukui, T. & Takeda, T. 1990. Plasma immunoreactive endothelin in essential hypertension. Am J Med 88, 614-618.
25. Lerman, A., Sandok, E.K., Hildebrand, F.L. Jr. & Burnett J.C. Jr 1992. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation 85, 1894-1898.
26. Lupien, J.R., Hirshman, M.F. & Horton, E.S. 1990. Effects of norepinephrine infusion on in vivo insulin sensitivity and responsiveness. Am J Physiol 259 (Endocrinol Metab 22), E210-E215.
27. Man, C.K. & Yoe, J.H. 1956. Spectrophotometric determination of magnesium with sodium 1-azo-2-hydroxy-3-(2,4-dimethylcarboxanilido)naphtalene-1′-(2- hydroxybenzene-5-sulphonate). Anal Chem 28, 202-205.
28. Newman, J.M.B., Dora, K.A., Rattigan, S., Edwards, S.J., Colquhoun, E.Q. & Clark, M.G. 1996. Norepinephrine and serotonin vasoconstriction in rat hindlimb control different vascular flow routes. Am J Physiol 270 (Endocrinol Metab 33), E689-E699.
29. Randall, M.D., Douglas, S.A. & Hiley, C.R. 1989. Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat. Br J Pharmacol 98, 685-699.
30. Rattigan, S., Dora, K.A., Colquhoun, E.Q. & Clark, M.G. 1993. Serotonin-mediated acute insulin resistance in the perfused rat hindlimb but not in incubated muscle: a role for the vascular system. Life Sci 53, 1545-1555.
31. Roden, M., Vierhapper, H., Liener, K. & Waldhausl., W. 1992. Endothelin-1-stimulated glucose production in vitro in the isolated perfused rat liver. Metabolism 41, 290-295.
32. Rowell, L.B., Blackmon, J.R. & Bruce, R.A. 1964. Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest 43, 1677-1690.
33. Rubanyi, G.M. & Polokoff, M.A. 1994. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46, 325-415.
34. Sakai, K., Imaizumi, T., Masaki, H. & Takeshita, A. 1993. Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension 22, 67-73.
35. Segal, S., Lloyd, S., Sherman, N., Sussman, K. & Draznin, B. 1990. Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin-dependent diabetes mellitus. Horm Res 34, 39-14.
36. Shangraw, R.E., Jahoor, F., Miyoshi, H., Neff, W.A., Stuart, C.A., Herndon, D.N. & Wolfe, R.R. 1989. Differentiation between septic and postburn insulin resistance. Metab Clin Exp 38, 983-989.
37. Sjöstrand, T. 1949. The total quantity of hemoglobin in man and its relation to age, sex, body weight and height. Acta Physiol Scand 18, 324-336.
38. Steinberg, H.O., Brechtel, G., Johnson, A., Fineberg, N. & Baron, A.D. 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. J Clin Invest 94, 1172-1179.
39. Takahashi, K., Ghatei, M.A., Lam, H.C., O'Halloran, D.J. & Bloom, S.R. 1990. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33, 306-310.
40. Touyz, R.M., Tolloczko, B. & Schiffrin, E.L. 1994. Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells. Hypertension 23, 125-128.
41. Wagner, O.F., Christ, G., Wojta, J., Vierhapper, H., Parzer, S., Nowotny, P.J., Schneider, B., Waldhäusl, W. & Binder, B.R. 1992. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267, 16066-16068.
42. Weitzberg, E., Ahlborg, G. & Lundberg., J.M. 1991b. Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues. Biochem Biophys Res Commun 180, 1298-1303.
43. Weitzberg, E., Ahlborg, G. & Lundberg, J.M. 1993. Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle, Clin Physiol 13, 653-662.
44. Weitzberg, E., Lundberg, J.M. & Rudehill, A. 1991a. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Sbock 33, 222-227.
45. Wide, L., Axén, R. & Porath, J. 1967. Radioimmunosorbent assay for proteins chemical couplings of antibodies to insoluble dextran. Immunochemistry 4, 381-386.
46. Williams, S.B., Cusco, J.A., Roddy, M. A., Johnstone, M.T. & Creager, M.A. 1996. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27, 567-574.
47. Yang, X.Y., Fekete, Z., Gardner, J., Benevenia, J. & Aviv, A. 1994. Endothelin mobilizes calcium and enhances glucose uptake in cultured human skeletal myoblasts and L6 myotubes. Hypertension 23, 1075-1081.
48. Yang, Y.J., Hope, I.D., Ader, M. & Bergman, R.N. 1989. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 84, 1621-1628.
49. 2+-regulation of insulin sensitivity. J Nutr 125, 1738S-1743S.